UNASSIGNED: Data were captured before and after OGEP on 561 lymphoedema patients in the community setting. Data recorded included resource use, costs and outcomes (EQ-5D-5L and LYMPROM).
UNASSIGNED: Data demonstrated statistically significant reductions in resource allocations including staff visits (P<0.001), cellulitis admissions (P<0.001), compression consumables and wound dressing costs (P<0.001). Overall, the total mean per patient cost decreased from £1457.10 to £964.40 (including intervention) with outcomes significantly improved in EQ-5D-5L/LYMPROM scores.
UNASSIGNED: The analysis suggests the OGEP intervention may offer reductions in resource costs and improvements in patient outcomes. OGEP may therefore provide an innovative solution in future care delivery.
■采集了社区环境中561名淋巴水肿患者OGEP前后的数据。记录的数据包括资源使用,成本和结果(EQ-5D-5L和LYMPROM)。
■数据表明,包括员工访问在内的资源分配在统计学上显著减少(P<0.001),蜂窝织炎入院(P<0.001),压缩耗材和伤口敷料成本(P<0.001)。总的来说,每位患者的总平均费用从1457.10英镑降至964.40英镑(包括干预措施),EQ-5D-5L/LYMPROM评分的结局显著改善.
分析表明,OGEP干预可能会降低资源成本并改善患者预后。因此,OGEP可以在未来的护理交付中提供创新的解决方案。